BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 11327016)

  • 1. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of free digoxin in sera of 8 patients with chronic cardiac insufficiency.
    Li JH; Pan H; Wu ZP; Chen YL; Chu XM; Lin SS
    Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):47-50. PubMed ID: 7771196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances.
    Koobatian TJ; Roberts JR
    Acad Emerg Med; 1995 Apr; 2(4):322-6. PubMed ID: 11727693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances.
    Dasgupta A
    Toxicol Rev; 2006; 25(4):273-81. PubMed ID: 17288498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidigoxin Fab fragments and digoxin monitoring: a challenge for the biologist].
    Parant F; Ducluzeau R; Lardet G; Gagnieu MC; Moulsma M
    Ann Biol Clin (Paris); 2003; 61(6):645-53. PubMed ID: 14711605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of the determination of serum digoxin levels (author's transl)].
    Babeau P; Bayada JM; Pras P; Lapalus P; Guiran JB
    Ann Med Interne (Paris); 1981; 132(2):109-14. PubMed ID: 7015953
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.